Open a Free Demat Account !
₹0 AMC & Account Opening Fee
Max Healthcare Ins
NSE: MAXHEALTH
Healthcare
Max Healthcare Ins (NSE: MAXHEALTH) share price today: live price, chart, fundamentals, shareholding pattern and news. Max Healthcare Ins is a listed company in the Healthcare sector (Hospital & Healthcare Services industry).
₹946.500.200.02%(1D)
Performance Stats for Max Healthcare Ins
Day Range
Low: ₹937.70
High: ₹953.00
52 Week Range
Low: ₹797.00
High: ₹1185.40
Open Price
947.00Previous Close
946.30Volume
1431381.00Open Price
947.00Previous Close
946.30Volume
1431381.00Fundamentals of Max Healthcare Ins
ROCE
10.27%
EPS
₹7.59
Dividend Yield
0.21%
P/E Ratio
130.66
P/B Ratio
10.47
Debt to Equity
0.08
Current Ratio
0.86
Sales Growth
10.12%
Profit Growth
13.08%
EBIT Growth
7.72%
Financials of Max Healthcare Ins
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Max Healthcare Ins
About Max Healthcare Ins
Max Healthcare Institute Limited was originally incorporated as Infinitum Technologies Private Limited at New Delhi, India as a Private Limited Company dated June 18 ,2001. Pursuant to a fresh Certificate of Incorporation dated June 28, 2002, the nam...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Dr Agarwals Health Care | ₹549.5 0.32% |
| Apollo Hospitals Enter | ₹8533 0.21% |
| Artemis Med Service | ₹324.85 2.56% |
| Aster Dm Quality Care | ₹723.9 1.63% |
Most Viewed Stocks
Open Interest (OI)
Max Healthcare Ins Options
| Price | OI | Volume |
Events Related to Max Healthcare Ins
Board Meeting
Oct 30, 2026
Board Meeting
Aug 13, 2026
AGM
Jul 30, 2026
Dividend
Jul 3, 2026
Board Meeting
May 21, 2026
News About Max Healthcare Ins
Aegis Logistics among 4 stocks showing RSI trending up
Sep 10, 2026
Delhivery, Titan Among CLSA"s Technical Breakout Picks — Check Upside, Target Price
Jul 15, 2026
Sumitomo Chemical among 4 stocks that closed crossing below VWAP
Jul 7, 2026
Goldman Sachs picks stakes in Jio Financial, BHEL via block deals. Check sellers
Mar 30, 2026
Max Health Q2 Results: Nifty's latest entrant reports 59% YoY jump in cons PAT to Rs 554 crore, revenue grows 21%
Nov 14, 2025

